KEI has created a public listserve to discuss vaccine manufacturing scale up. (link)
KEI has gathered data regarding vaccine manufacturing capacity in countries worldwide, across different vaccine technology platform, as well as on the outsourcing of manufacturing.
- KEI Notes on Vaccine Manufacturing Capacity outlines the manufacturers currently involved in COVID-19 vaccine manufacturing, and highlights potential COVID-19 vaccine manufacturing facilities.
- Examples of COVID-19 outsourcing/tech transfer deals provides some data on the actual sharing of manufacturing know-how, between firms.
Selected SEC filings of interest
KEI has also compiled articles regarding the Oxford/AstraZeneca COVID-19 vaccine and the role of Gates in the exclusive licensing decision. “Notes and references to some of the new stories about the Gates role in Oxford granting an exclusive license.”